Viatris (VTRS) Treasury Shares (2019 - 2026)
Viatris (VTRS) posted quarterly Treasury Shares of $1.0 billion for Q1 2026, up 48.15% year-over-year from $679.8 million in Q1 2025, and little changed quarter-over-quarter from $1.0 billion in Q4 2025.
Viatris (VTRS) Treasury Shares (2019 - 2026) Analysis & Trends
Viatris' Treasury Shares history runs 5 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- In Q1 2026, Treasury Shares rose 48.15% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (up 48.15% YoY), while the FY2025 annual figure was $1.0 billion, up 99.72% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.0 billion, roughly flat from $1.0 billion in the prior quarter.
- The five-year high for Treasury Shares was $24.6 million in Q4 2019, with the low at $18.1 million in Q2 2021.
- The 3-year median for Treasury Shares is $21.7 million (2019), against an average of $21.5 million.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 100.28% in 2024, then surged 34.8% in 2025.
- Viatris' Treasury Shares stood at $251.8 million in 2023, then soared by 100.28% to $504.3 million in 2024, then jumped by 99.72% to $1.0 billion in 2025, then dropped by 0.01% to $1.0 billion in 2026.
- Business Quant data shows VTRS's Treasury Shares at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $924.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 924.20 Mn |
| Sep 30, 2025 | 924.20 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |